E
Ersell Richardson
Researcher at National Institutes of Health
Publications - 12
Citations - 1739
Ersell Richardson is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Simian immunodeficiency virus & ELISPOT. The author has an hindex of 10, co-authored 12 publications receiving 1706 citations.
Papers
More filters
Journal ArticleDOI
Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)
Robert C. Gallo,Prem S. Sarin,Edward P. Gelmann,Marjorie Robert-Guroff,Ersell Richardson,V. S. Kalyanaraman,Dean L. Mann,Gurdip D. Sidhu,Rosalyn E. Stahl,Susan Zolla-Pazner,Jacque Leibowitch,Mikulas Popovic +11 more
TL;DR: Whether or not HTLV-I or other retroviruses of this family with T-cell tropism cause AIDS, it is possible that patients from whom the virus can be isolated can also transmit it to others.
Journal ArticleDOI
An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge.
S. L. Buge,Ersell Richardson,S. Alipanah,P. D. Markham,S. M. Cheng,Narender K. Kalyan,Christopher J. Miller,Michael D. Lubeck,Stephen A. Udem,John H. Eldridge,Marjorie Robert-Guroff +10 more
TL;DR: It is shown that a vaccine regimen using the Ad5hr-SIV env recombinant and gp120 subunit induces strong humoral, cellular, and mucosal immunity in rhesus macaques, and supports further development of Ad-based vaccines comprising additional viral components for immune therapy and AIDS vaccine development.
Journal ArticleDOI
Vaccine Protection against a Heterologous, Non-Syncytium-Inducing, Primary Human Immunodeficiency Virus
Marjorie Robert-Guroff,Harvinder Kaur,L. Jean Patterson,Michel Leno,Anthony J. Conley,Philip M. McKenna,Phillip D. Markham,Ersell Richardson,Kristine Aldrich,Kamalpreet Arora,Lalita C. Murty,Lucretia Carter,Susan Zolla-Pazner,Faruk Sinangil +13 more
TL;DR: The results demonstrate the potential of this combination vaccine strategy and suggest that vaccine protection against an HIV isolate relevant to infection of people is feasible.
Journal ArticleDOI
Potent, Persistent Induction and Modulation of Cellular Immune Responses in Rhesus Macaques Primed with Ad5hr-Simian Immunodeficiency Virus (SIV) env/rev, gag, and/or nef Vaccines and Boosted with SIV gp120
L. Jean Patterson,Nina Malkevitch,Joel Pinczewski,David Venzon,Yuanmei Lou,Bo Peng,Cindy Munch,Melissa Leonard,Ersell Richardson,Kristine Aldrich,Vaniambadi S. Kalyanaraman,George N. Pavlakis,Marjorie Robert-Guroff +12 more
TL;DR: Immunity elicited by multicomponent vaccines delivered by replication-competent Ad5hr-simian immunodeficiency virus (SIV) recombinants was systematically investigated and modulation of this cellular immune response was observed among macaques receiving one, two, or three Ad5HR-SIV recombinant
Journal ArticleDOI
Factors Associated with Slow Disease Progression in Macaques Immunized with an Adenovirus-Simian Immunodeficiency Virus (SIV) Envelope Priming-gp120 Boosting Regimen and Challenged Vaginally with SIVmac251
Suzan L. Buge,Lalita C. Murty,Kamalpreet Arora,Vaniambadi S. Kalyanaraman,Phillip D. Markham,Ersell Richardson,Kristine Aldrich,L. Jean Patterson,Christopher J. Miller,Sheau-Mei Cheng,Marjorie Robert-Guroff +10 more
TL;DR: The partial protection against a virulent, pathogenic SIV challenge observed in two of six macaques immunized with a vaccine regimen based solely on the viral envelope indicates that this vectored-vaccine approach has promise and that multicomponent vaccines based in the same system merit further investigation.